Related Experiment Video
Updated: Jun 17, 2026

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models
Published on: September 6, 2024
Antiproliferative and proapoptotic actions of okra pectin on B16F10 melanoma cells
Muriel Vayssade1, Nipaporn Sengkhamparn, René Verhoef
1UMR CNRS 6600, Université de Technologie de Compiègne, France.
Abstract:
The proliferation and apoptosis of metastatic melanoma cells are often abnormal. We have evaluated the action of a pectic rhamnogalacturonan obtained by hot buffer extraction of okra pods (okra RG-I) on melanoma cell growth and survival in vitro. We added okra RG-I containing an almost pure RG-I carrying very short galactan side chains to 2D (on tissue culture polystyrene, tPS) and 3D (on poly(2-hydroxyethylmethacrylate), polyHEMA) cultures of highly metastatic B16F10 mouse melanoma cells. We then analyzed cell morphology, proliferation index, apoptosis, cell cycle progression and the expression of adhesion molecules. Immunostaining and western blotting were used to assay galectin-3 (Gal-3) protein.Incubation with okra RG-I altered the morphology of B16F10 cells and significantly reduced their proliferation on both tPS and polyHEMA. The cell cycle was arrested in G2/M, and apoptosis was induced, particularly in cells on polyHEMA. The expression of N-cadherin and alpha5 integrin subunit was reduced and that of the multifunctional carbohydrate-binding protein, Gal-3, at the cell membrane increased.These findings suggest that okra RG-I induces apoptosis in melanoma cells by interacting with Gal-3. As these interactions might open the way to new melanoma therapies, the next step will be to determine just how they occur.
Insights
Okra rhamnogalacturonan (RG-I) inhibits melanoma cell growth and survival. This natural compound induces apoptosis and alters cell adhesion molecules, suggesting potential for novel melanoma therapies.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Metastatic melanoma exhibits abnormal cell proliferation and apoptosis.
- Investigating natural compounds for anti-cancer properties is crucial.
Purpose of the Study:
- To evaluate the effect of okra pectic rhamnogalacturonan (okra RG-I) on melanoma cell growth and survival.
- To explore the potential of okra RG-I as a therapeutic agent against melanoma.
Main Methods:
- In vitro study using 2D and 3D cultures of B16F10 mouse melanoma cells.
- Analysis of cell morphology, proliferation, apoptosis, cell cycle, and adhesion molecule expression.
- Immunostaining and western blotting to detect galectin-3 (Gal-3) protein.
Main Results:
- Okra RG-I significantly reduced melanoma cell proliferation in both 2D and 3D cultures.
- Cell cycle arrest at G2/M phase and induced apoptosis were observed, particularly in 3D cultures.
- Alterations in adhesion molecules (decreased N-cadherin and alpha5 integrin) and increased cell membrane Gal-3 expression were noted.
Conclusions:
- Okra RG-I demonstrates anti-proliferative and pro-apoptotic effects on melanoma cells.
- The interaction between okra RG-I and Gal-3 may mediate its anti-melanoma activity.
- Further research is warranted to elucidate the precise mechanisms for potential therapeutic applications.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation